Natural product-derived therapy for Allergic rhinitis: γ-Bisabolene, one of the main components of Cardamom, cubeb, oregano, and lemon among others, inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene, 4/April/2017, 7.03 am

Natural product/vitamin-based Combination therapy for PTEN-deficient cancer: Combination of Boehmenan, Cholecalciferol and Metformin decreases the expression of CHD1, increases the expression of a number of tumor suppressor genes, inhibits pro-survival TNF-NF-kB gene network, and suppresses tumorigenesis of PTEN-deficient cancer, 4/April/2017, 12.05 am
April 3, 2017
Natural product-derived antiviral therapy against Neuroinvasive West Nile virus: Cucurbitacin E, found abundantly in water melons, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 4/April/2017, 8.14 am
April 4, 2017
Show all

What we say:

Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Allergic rhinitis: γ-Bisabolene, one of the main components of Cardamom, cubeb, oregano, and lemon among others,  inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene


From Significance of the study to Public health relevance:

Given that: (1) in any given year, nearly 20-30% of people are affected by Allergic Rhinitis; (2) most of the medications available today for allergic rhinitis treats only the symptoms, and provide temporary relief; (3) corticosteroid therapy for allergic rhinitis may have its own side effects; (4) the global economic cost spent in the treatment of allergic rhinitis is enormous, there is an urgent need to find: (i) a way to cure allergic rhinitis, without adverse side effects; (ii) a cheaper alternative to the existing expensive medications; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, allergic rhinitis.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a natural product based therapy for Allergic Rhinitis. γ-Bisabolene, by increasing the expression of its target genes, it may: (1) inhibit GM-CSF levels; (2) decrease IL13Rα1 expression; (3) suppress eotaxin expression; and (4) inhibit mucus production (figs. 1-5).

க்கான பட முடிவு

Figure 1. The chemical structure of γ-Bisabolene

γ-Bisabolene க்கான பட முடிவு

Figure 2. Cardamom. γ-Bisabolene, found in Cardamom, among others, as indicated below, inhibits the development and progression of Allergic Rhinitis

lemons க்கான பட முடிவு

Figure 3. Lemon fruits.

cubeb க்கான பட முடிவு

Figure 4. Cubeb

oregano க்கான பட முடிவு

Figure 5 Oregano

Thus, pharmacological formulations encompassing γ-Bisabolene or its analogues either alone or in combination with other drugs” may be used to control allergic rhinitis.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does γ-Bisabolene decrease the expression of GM-CSF/L13Ra1/eotaxin to inhibit allergic rhinitis?

Amount: $50

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L., Natural product-derived therapy for Allergic rhinitis: γ-Bisabolene, one of the main components of Cardamom, cubeb, oregano, and lemon among others,  inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene, 4/April/2017, 7.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.